Evidence map›Paper›PMID 38448383›Full record

ArticleZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences2023

Research progress on the dermatomyositis specific autoantibodies and malignancy associated dermatomyositis.

Yue Xu, Yang Yang, Songqing Fan

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Muscle weakness with a hidden cause.BMJ case reports · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Yue XuDepartment of Pathology, Second Xiangya Hospital, Central South University, Changsha 410011, China. 218211011@csu.edu.cn.
Yang YangDepartment of Pathology, Second Xiangya Hospital, Central South University, Changsha 410011, China.
Songqing FanDepartment of Pathology, Second Xiangya Hospital, Central South University, Changsha 410011, China. songqingfan@csu.edu.cn.
Second Xiangya Hospital of Central South University · CN

Funding

the National Natural Science Foundation of China 81972838
6 · The paper itself

Abstract

Dermatomyositis (DM) is an autoimmune disease often complicated with malignant tumors. More than 50% of DM patients have myositis specific autoantibodies in their bodies. DM specific autoantibodies [including anti-migration inhibitory factor (Mi)-2 antibody, anti-nuclear matrix protein (NXP)-2 antibody, anti-transcription intermediary factor (TIF) 1-γ antibody, and anti-small ubiquitin like modifier activating enzyme (SAE) antibody] play important roles in the pathogenesis of malignancy associated DM. Revealing the role of DM specific autoantibodies in the development of malignant tumors in DM patients can provide important evidence for accurately assessing the risk of developing malignant tumors in DM patients, and also provide new ideas for clinical diagnosis of DM and precise treatment.

Indexed as

Autoimmune DiseasesDermatomyositisNeoplasmsAutoantibodiesHumansAutoantibodiesdermatomyositismalignant tumorsmigration inhibitory factor-2nuclear matrix protein-2small ubiquitin-like modifier activating enzymespecific autoantibodytranscription intermediary factor 1-γ

Identifiers

PMID38448383
PMCPMC10930743
OpenAlexW4394760941

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.